NVO
Novo Nordisk A/S
NVO trails on the overall score without a compensating advantage in the available component scores.
PODD
Insulet Corporation
PODD has the edge over NVO overall, supported by stronger modeled upside and stronger fundamentals.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
PODD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
PODD's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
PODD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 20x | $149 | — |
| Current | 24x | $149 | — |
| Cheap | 45x | $277 | +86% |
| Fair | 136x | $835 | +459% |
| Expensive | 1,179x | $7,213 | +4732% |
Historical ranges are pointers, not guarantees.
PODD has the edge over NVO in the historical PE scenario, which offers more potential upside but is not a forecast.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
PODD Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
PODD has the edge over NVO on the outlook, with more favorable earnings and profitability expectations.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO's earnings per share have climbed steadily: $3.89 over the past year, up 4.9% from the year before, and higher year over year every quarter since late 2020.
PODD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.52 | +23% |
| Q3 2026 | $6.12 | +78% |
| Q2 2026 | $5.33 | +63% |
| Q1 2026 | $4.28 | -23% |
| Q4 2025 | $3.48 | -40% |
| Q3 2025 | $3.44 | -41% |
| Q2 2025 | $3.28 | -41% |
| Q1 2025 | $5.55 | +67% |
| Q4 2024 | $5.78 | +97% |
PODD earned $6.12 per share over the past year, up 78% from the year before.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over PODD on profitability, with a higher operating margin.
PODD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $842M | +19% |
| Q2 2026 | $801.7M | +24% |
| Q1 2026 | $761.7M | +34% |
| Q4 2025 | $783.8M | +31% |
| Q3 2025 | $706.3M | +30% |
| Q2 2025 | $649.1M | +33% |
| Q1 2025 | $569M | +29% |
| Q4 2024 | $597.5M | +17% |
PODD has the edge over NVO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +5.9 points |
| Q2 2026 | 16% | -2.5 points |
| Q1 2026 | 16% | +0.4 points |
| Q4 2025 | 19% | +0.4 points |
| Q3 2025 | 17% | +0.5 points |
| Q2 2025 | 19% | +7.5 points |
| Q1 2025 | 16% | +2.7 points |
| Q4 2024 | 18% | -2.6 points |
PODD's operating margin was 23% last quarter, up 5.9 points from the same quarter a year ago, near the top of its range since 2019.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over PODD on cash flow, with more consistent year-over-year improvement.
PODD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $66.4M | -34% |
| Q2 2026 | $55.9M | -69% |
| Q1 2026 | $89.5M | +74% |
| Q4 2025 | $48.2M | -49% |
| Q3 2025 | $100.1M | +39% |
| Q2 2025 | $177.9M | +140% |
| Q1 2025 | $51.5M | -21% |
| Q4 2024 | $94.1M | +492% |
PODD still generates free cash flow, though less than at its 2025 peak: $260M over the past year.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has 4.4B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
PODD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +89K shares |
| 1 year | -1.7% | -1.2M shares |
| 3 years | -5.6% | -4.1M shares |
| 5 years | -0.2% | -127K shares |
| Available history | +12% | +7.2M shares |
PODD has the edge over NVO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $300M |
| Q4 2025 | — |
| Q3 2025 | $29.5M |
PODD spent $300M buying back its own shares over the past year.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
PODD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | 0.4x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.6x | Very low |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 1.1x | Healthy |
PODD's net debt is less than a year of its operating earnings (EBITDA).
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
PODD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.0 | Neutral |
| Stochastic | 48.9 | Neutral |
PODD's weekly RSI is 44 (neutral) and its Stochastic is 49 (neutral).
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO has the edge over PODD on valuation relative to its sector.
PODD PE vs Healthcare Sector
| Metric | PODD | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 26x | 5.6% below |
| PE % | 0 | 29 | 29 pts below |
PODD is trading at 24x earnings, in line with the Healthcare sector's median of 26x.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 50% below its 200-week average.
PODD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $142.3 | 4.9% above |
| 20 week MA | $147.8 | 1% above |
| 50 week MA | $191.3 | 22% below |
| 100 week MA | $243.7 | 39% below |
| 200 week MA | $234.4 | 36% below |
PODD has the edge over NVO on trend strength, trading above more of its moving averages.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over PODD on returns for 2026, with the stronger performance.
PODD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $172.5 | $257.3 | +49% |
| 2021 | $257.3 | $273.3 | +6.2% |
| 2022 | $273.3 | $292.1 | +6.9% |
| 2023 | $292.1 | $217.0 | -26% |
| 2024 | $217.0 | $265.1 | +22% |
| 2025 | $265.1 | $288.6 | +8.9% |
| 2026 YTD | $288.6 | $149.3 | -48% |
PODD is down 48% so far in 2026, after finishing higher in five of the previous six years.